Heinz Kirchen

1.8k total citations
10 papers, 480 citations indexed

About

Heinz Kirchen is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Heinz Kirchen has authored 10 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Heinz Kirchen's work include CNS Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Heinz Kirchen is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Heinz Kirchen collaborates with scholars based in Germany, Austria and Switzerland. Heinz Kirchen's co-authors include Katharina S. Götze, Konstanze Döhner, Elisabeth Koller, Frank Hartmann, Hartmut Döhner, Axel Benner, Richard F. Schlenk, Agnieszka Korfel, Kristoph Jahnke and Peter Martus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Heinz Kirchen

10 papers receiving 467 citations

Peers

Heinz Kirchen
Heinz Kirchen
Citations per year, relative to Heinz Kirchen Heinz Kirchen (= 1×) peers Maryse Power

Countries citing papers authored by Heinz Kirchen

Since Specialization
Citations

This map shows the geographic impact of Heinz Kirchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Kirchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Kirchen more than expected).

Fields of papers citing papers by Heinz Kirchen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinz Kirchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Kirchen. The network helps show where Heinz Kirchen may publish in the future.

Co-authorship network of co-authors of Heinz Kirchen

This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Kirchen. A scholar is included among the top collaborators of Heinz Kirchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Kirchen. Heinz Kirchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Herrlinger, Ulrich, Niklas Schäfer, Rolf Fimmers, et al.. (2017). Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. Journal of Cancer Research and Clinical Oncology. 143(9). 1815–1821. 49 indexed citations
2.
Korfel, Agnieszka, Michael Weller, Peter Martus, et al.. (2012). Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Annals of Oncology. 23(9). 2374–2380. 39 indexed citations
3.
Schlenk, Richard F., Konstanze Döhner, Silja Mack, et al.. (2010). Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A. Journal of Clinical Oncology. 28(30). 4642–4648. 158 indexed citations
4.
Schlenk, Richard F., Konstanze Döhner, Michael Kneba, et al.. (2008). Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. Haematologica. 94(1). 54–60. 144 indexed citations
6.
Schlenk, Richard F., Konstanze Doehner, Frank Hartmann, et al.. (2005). All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.. Blood. 106(11). 1849–1849. 2 indexed citations
7.
Korfel, Agnieszka, Peter Martus, Mohammad R. Nowrousian, et al.. (2004). Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma. British Journal of Haematology. 128(2). 177–183. 41 indexed citations
8.
Fischer, L., E. Thiel, H. Klasen, et al.. (2004). Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan. Neurology. 62(10). 1885–1887. 33 indexed citations
9.
Korfel, Agnieszka, Peter Martus, DK Hossfeld, et al.. (2003). A prospective Multicenter study of the BMPD regimen with or without radiotherapy for primary CNS lymphoma.. mediaTUM (Technical University of Munich). 1 indexed citations
10.
Kirchen, Heinz, et al.. (1987). The mapping of chromosomes in Saccharomyces cerevisiae. Gene. 53(2-3). 181–190. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026